{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:58:23Z","timestamp":1778716703260,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.hrtlng.2010.07.019","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T19:09:01Z","timestamp":1324667341000},"page":"95-98","source":"Crossref","is-referenced-by-count":6,"title":["A case for immediate-release niacin"],"prefix":"10.1016","volume":"41","author":[{"given":"Mayer","family":"Bassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2010.07.019_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCULATIONAHA.106.667428","article-title":"Lipid management to reduce cardiovascular risk: a new strategy is required","volume":"117","author":"Superko","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib3","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jacc.2009.06.036","article-title":"Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study","volume":"54","author":"Lee","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima-media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.1994.03510330087041","article-title":"Over-the-counter niacin","volume":"271","author":"Lasagna","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.1961.03040340010003","article-title":"Nicotinic acid treatment of hypercholesterolemia. Comparison of plain and sustained-action preparations and report of two cases of jaundice","volume":"177","author":"Christensen","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A\u00a0comparison of the efficacy and toxic effects of sustained- vs. immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0026-0495(85)90092-7","article-title":"Contrasting effects of unmodified and time- release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin","volume":"34","author":"Knopp","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(91)90122-E","article-title":"Niacin revisited: clinical observations on an important but underutilized drug","volume":"91","author":"Henkin","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJMcp044370","article-title":"Low HDL cholesterol levels","volume":"353","author":"Ashen","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archinte.1994.00420140051007","article-title":"Comparative effects of lovastatin and niacin in primary hypercholesterolemia","volume":"154","author":"Illingworth","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-3-4","article-title":"The safety of over-the-counter niacin. A randomized placebo-controlled trial","volume":"3","author":"Mills","year":"2003","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjcard.2009.02.047","article-title":"Flushing profile of extended-release niacin\/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease","volume":"104","author":"Maccubbin","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2010.07.019_bib18","series-title":"Cholesterol control without diet","author":"Parsons","year":"1998"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795631000302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795631000302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T08:21:50Z","timestamp":1539678110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014795631000302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S014795631000302X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2010.07.019","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}